Sort   by:  
 Page size 
UnknownData on the identification of VRK2 as a mediator of PD-1 function.
Not available
S-EPMC8170101 | biostudies-literature
UnknownA novel mouse model for checkpoint inhibitor-induced adverse events.
Not available
S-EPMC7877613 | biostudies-literature
UnknownLocal adaptation and future climate vulnerability in a wild rodent.
Not available
S-EPMC10686993 | biostudies-literature
UnknownTransmembrane adaptor protein PAG is a mediator of PD-1 inhibitory signaling in human T cells.
Not available
S-EPMC8175585 | biostudies-literature
UnknownPD-1-stimulated T cell subsets are transcriptionally and functionally distinct.
Not available
S-EPMC8426269 | biostudies-literature
UnknownNeutralization of the adaptor protein PAG by monoclonal antibody limits murine tumor growth.
Not available
S-EPMC9664140 | biostudies-literature
UnknownEF Hand Domain Family Member D2 Is Required for T Cell Cytotoxicity.
Not available
S-EPMC6200634 | biostudies-literature
UnknownSHP2 Targets ITK Downstream of PD-1 to Inhibit T Cell Function.
Not available
S-EPMC9199348 | biostudies-literature
UnknownThe structural features that distinguish PD-L2 from PD-L1 emerged in placental mammals.
Not available
S-EPMC7135984 | biostudies-literature
UnknownInhibition of IL-25/IL-17RA improves immune-related adverse events of checkpoint inhibitors and reveals antitumor activity.
Not available
S-EPMC10961528 | biostudies-literature
Sort   by:  
 Page size